Biofrontera Inc. (BFRI)
USD 0.83
(4.39%)
USD 0.83
(4.39%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 34.07 Million USD | 18.82% |
| 2022 | 28.67 Million USD | 18.98% |
| 2021 | 24.1 Million USD | 27.86% |
| 2020 | 18.84 Million USD | -28.01% |
| 2019 | 26.18 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 7.83 Million USD | -0.78% |
| 2024 Q1 | 7.9 Million USD | -25.43% |
| 2023 Q3 | 8.87 Million USD | 51.83% |
| 2023 FY | 34.07 Million USD | 18.82% |
| 2023 Q4 | 10.59 Million USD | 19.34% |
| 2023 Q2 | 5.84 Million USD | -33.04% |
| 2023 Q1 | 8.73 Million USD | -13.91% |
| 2022 Q2 | 4.45 Million USD | -54.29% |
| 2022 Q1 | 9.75 Million USD | 6.36% |
| 2022 FY | 28.67 Million USD | 18.98% |
| 2022 Q4 | 10.14 Million USD | 134.71% |
| 2022 Q3 | 4.32 Million USD | -3.03% |
| 2021 FY | 24.1 Million USD | 27.86% |
| 2021 Q4 | 9.16 Million USD | 111.54% |
| 2021 Q3 | 4.33 Million USD | -25.98% |
| 2021 Q2 | 5.85 Million USD | 23.42% |
| 2021 Q1 | 4.74 Million USD | -44.66% |
| 2020 Q2 | 2.4 Million USD | -48.04% |
| 2020 FY | 18.84 Million USD | -28.01% |
| 2020 Q4 | 8.57 Million USD | 163.59% |
| 2020 Q3 | 3.25 Million USD | 35.39% |
| 2020 Q1 | 4.62 Million USD | 0.0% |
| 2019 FY | 26.18 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Intra-Cellular Therapies, Inc. | 464.37 Million USD | 92.663% |
| PainReform Ltd. | - USD | -Infinity% |
| Alvotech | 91.43 Million USD | 62.737% |
| Collegium Pharmaceutical, Inc. | 566.76 Million USD | 93.989% |
| ANI Pharmaceuticals, Inc. | 486.81 Million USD | 93.001% |
| Aquestive Therapeutics, Inc. | 50.58 Million USD | 32.643% |
| Journey Medical Corporation | 79.18 Million USD | 56.971% |
| Dynavax Technologies Corporation | 232.28 Million USD | 85.332% |
| Esperion Therapeutics, Inc. | 116.33 Million USD | 70.713% |
| Bright Green Corporation | 401.49 Thousand USD | -8386.118% |
| Pacira BioSciences, Inc. | 674.97 Million USD | 94.952% |
| Embecta Corp. | 1.12 Billion USD | 96.96% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -41.416% |
| Sunshine Biopharma, Inc. | 24.09 Million USD | -41.416% |
| SCYNEXIS, Inc. | 140.14 Million USD | 75.688% |
| Petros Pharmaceuticals, Inc. | 5.82 Million USD | -485.172% |
| Silver Spike Investment Corp. | 11.72 Million USD | -190.655% |
| China SXT Pharmaceuticals, Inc. | 1.92 Million USD | -1666.713% |
| Alpha Teknova, Inc. | 36.68 Million USD | 7.123% |
| Safety Shot Inc | 202.67 Thousand USD | -16711.072% |
| Procaps Group, S.A. | 409.92 Million USD | 91.688% |
| Cosmos Health Inc. | 53.37 Million USD | 36.169% |
| Theratechnologies Inc. | 81.76 Million USD | 58.33% |
| Harrow Health, Inc. | 130.19 Million USD | 73.83% |
| Sonoma Pharmaceuticals, Inc. | 12.73 Million USD | -167.538% |
| DURECT Corporation | 8.54 Million USD | -298.584% |
| Supernus Pharmaceuticals, Inc. | 607.52 Million USD | 94.392% |
| Cronos Group Inc. | 88.84 Million USD | 61.649% |
| OptiNose, Inc. | 70.98 Million USD | 52.004% |
| Ironwood Pharmaceuticals, Inc. | 442.73 Million USD | 92.304% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 6.51 Million USD | -423.109% |
| Organogenesis Holdings Inc. | 433.14 Million USD | 92.134% |
| Guardion Health Sciences, Inc. | 12.24 Million USD | -178.164% |
| Cumberland Pharmaceuticals Inc. | 39.55 Million USD | 13.859% |
| Radius Health, Inc. | 2.88 Billion USD | 98.818% |
| Universe Pharmaceuticals INC | 32.3 Million USD | -5.454% |
| ProPhase Labs, Inc. | 44.38 Million USD | 23.236% |
| Phibro Animal Health Corporation | 1.01 Billion USD | 96.652% |
| Procaps Group S.A. | 409.92 Million USD | 91.688% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -2516.82% |
| Viatris Inc. | 15.42 Billion USD | 99.779% |
| Rockwell Medical, Inc. | 83.61 Million USD | 59.251% |
| Aytu BioPharma, Inc. | 81 Million USD | 57.938% |
| SIGA Technologies, Inc. | 139.91 Million USD | 75.649% |
| Tilray Brands, Inc. | 788.94 Million USD | 95.681% |
| Lifecore Biomedical, Inc. | 128.26 Million USD | 73.436% |
| Shineco, Inc. | 9.8 Million USD | -247.597% |
| PetIQ, Inc. | 1.1 Billion USD | 96.908% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 12 Thousand USD | -283825.0% |
| Neurocrine Biosciences, Inc. | 1.88 Billion USD | 98.195% |
| Alimera Sciences, Inc. | 80.75 Million USD | 57.809% |
| Assertio Holdings, Inc. | 152.06 Million USD | 77.595% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Clever Leaves Holdings Inc. | 17.41 Million USD | -95.619% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -3065.258% |
| Avadel Pharmaceuticals plc | 27.96 Million USD | -21.843% |
| Hempacco Co., Inc. | 4.04 Million USD | -742.167% |
| Talphera, Inc. | 651 Thousand USD | -5133.641% |
| Alvotech | 91.43 Million USD | 62.737% |
| Eagle Pharmaceuticals, Inc. | 316.61 Million USD | 89.239% |
| Lantheus Holdings, Inc. | 1.29 Billion USD | 97.372% |
| Currenc Group, Inc. | 53.25 Million USD | 36.023% |
| Kamada Ltd. | 144.75 Million USD | 76.464% |
| Indivior PLC | 1.09 Billion USD | 96.883% |
| Evoke Pharma, Inc. | 5.18 Million USD | -557.661% |
| Flora Growth Corp. | 76.07 Million USD | 55.212% |
| Cyclo Therapeutics, Inc. | 1.07 Million USD | -3065.258% |
| Evolus, Inc. | 202.08 Million USD | 83.14% |
| HUTCHMED (China) Limited | 837.99 Million USD | 95.934% |
| Amphastar Pharmaceuticals, Inc. | 644.39 Million USD | 94.713% |
| Akanda Corp. | 2.16 Million USD | -1477.323% |